Enrique Chacón
@Quique_ChC
Followers
791
Following
2K
Media
60
Statuses
722
Gynecologic Oncologist at Clinica Universidad de Navarra. Educational videos always with consent. @IJGConline editorial fellow. #ESGO2022 SoMe ambassador.
Pamplona
Joined September 2012
Honoured to join the #AAGOCongress as speaker:. 💡 Latest advances in cervical cancer surgery.📊 Results from our #SENECA study on molecular classification in endometrial cancer.🗡️ Surgical anatomy & complications — sharing tips for safe radical procedures. Amazing hospitality🇦🇷
1
0
13
RT @IJGConline: #Editorial Back to the past ⌛ should positive peritoneal cytology influence patient management in low-risk #endometrialcanc….
0
8
0
RT @IJGConline: #LeadArticle Positive #peritonealcytology predicts higher recurrence risk in low-risk #endometrialcancer. 📉 Worse 5-year re….
0
13
0
Back to the past: should positive peritoneal cytology influence patient management in low-risk endometrial cancer?. Find the answer in our editorial of the July´s lead article of @IJGConline . Thank you @pedroramirezMD for the opportunity! .
0
1
12
RT @IJGConline: 📊 Impact Factor Alert!.We’re proud to share that #IJGC's #ImpactFactor has increased to 4.7 in the 2024 Journal Citation Re….
0
19
0
El 6 de junio celebramos el 10º aniversario del inicio de nuestra residencia en la @ClinicaNavarra. Reencuentro emocionante, cálida bienvenida de @CamposJoseba, reflexiones sabias de los Prof. Quiroga y Pardo, y muchas ganas de seguir construyendo juntos!. ¡Nos vemos en el 20º!
0
1
15
RT @lchiv4: Would you like to see the curves, maps, and tools we used in SUROVA?.We’ll be posting key visuals and mini-threads in the comin….
0
2
0
RT @lchiv4: 🎯 SUROVA shows there’s no one-size-fits-all treatment. The key is individualization:.✔️ Disease burden.✔️ Performance status.✔️….
0
2
0
RT @lchiv4: What if we could predict surgical frailty before treatment starts?.That's exactly what SUROVA aims to do. 📱 We’ve built a pre-t….
0
2
0
RT @lchiv4: ❗Even moderate complications (Grade II) lower overall survival. But more importantly:.They reveal an underlying patient frailty….
0
2
0
RT @lchiv4: 🧠 We found something unexpected:.The survival curves cross at 18 months. 🔺 NACT shows better outcomes early on. 🔻 PDS shows bet….
0
2
0
RT @lchiv4: 🌍 56 countries. 174 hospitals. 3,500 patients. SUROVA compares two initial treatment strategies:.1️⃣ Primary debulking surgery….
0
1
0
RT @lchiv4: 🔬 What did we learn from analyzing 3,500 women with advanced ovarian cancer from across the globe?.SUROVA is the largest real-w….
0
3
0
RT @lchiv4: Combined conclusions from SUROVA + TRUST:.✅ Primary surgery gives the best long-term outcomes — if done safely.✅ NACT is a soli….
0
10
0
RT @lchiv4: 8/ Welcome to the era of personalized treatment in ovarian cancer. 🔬 Surgery first— yes, but selecting pts.📊 Data — yes, but w….
0
1
0
RT @lchiv4: 7/ Two studies. One conclusion. One proves it through randomization, the other through real-world data. 👉 TRUST confirms. SUROV….
0
1
0
RT @lchiv4: 7/ Combined conclusions from SUROVA + TRUST:.✅ Primary surgery gives the best long-term outcomes — if done safely.✅ NACT is a s….
0
2
0
RT @lchiv4: 6/Even grade II complications negatively affect survival outcomes and represent a marker of patient frailty, as clearly illustr….
0
1
0
RT @lchiv4: 5/ Why is this so important?.Because if we can predict which patients are at risk for complications. ➡️ We can individualize….
0
1
0